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Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, Perkins BA, Harris SB, Zinman B, Hanley AJ. Association
of vitamin D with insulin resistance and -cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care
2010;33:1379–1381
Intheprintversionofthearticlelistedabove,anerrorappearswithinthetextthataffectstheinterpretationoftheresults.Itisstated
in the RESEARCH DESIGN AND METHODS at the end of the ﬁrst paragraph (p. 1379) and in the CONCLUSIONS in the middle of both the ﬁrst
and third paragraphs (p. 1380) that all subjects were free of diabetes as conﬁrmed by oral glucose tolerance tests (OGTTs). While
we conﬁrm that none of the subjects had known diabetes at the time of the assessments, a small proportion (8%) had an OGTT
abnormalityofearlydiabetes,withthevastmajorityofthesesubjects(88%)classiﬁedbasedona2-hglucosevalueof11.0mmol/l.
Inthe RESEARCH DESIGN AND METHODSsection,ﬁrstparagraph(p.1379),thelastsentenceshouldread,“Thecurrentstudyincludes712
subjects, 92% of whom were free of diabetes based on oral glucose tolerance tests (OGTTs). None had known diabetes at the time
of the assessments.” In the CONCLUSIONS section, ﬁrst paragraph, the ﬁrst sentence should read, “This study demonstrated indepen-
dent associations of 25(OH)D with both insulin sensitivity and -cell function in subjects without known diabetes, the majority of
whom were free of diabetes based on OGTTs.” In the CONCLUSIONS section, third paragraph, the second sentence should read, “In
addition, the current study included a large, well-characterized multiethnic sample.” The online version reﬂects these changes.
Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW,
Kirkman MS. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the
American Diabetes Association, a scientiﬁc statement of the American Heart Association, and an expert consensus docu-
ment of the American College of Cardiology Foundation. Diabetes Care 2010;33:1395–1402
Because of a typographical error in the erratum previously published for the article listed above, three of the study names in Fig. 1
were incorrect. In Fig. 1A, “UKMD” should read “BMD.” In Fig. 1B, “USP” should read “PHS” and “BDS” should read “BMD.” These
errors do not affect the data. The online version reﬂects these changes.
care.diabetesjournals.org DIABETES CARE, VOLUME 34, NUMBER 1, JANUARY 2011 247Figure1—Meta-analysisoftrialsexaminingtheeffectsofaspirinonriskofCVDeventsinpatientswithdiabetes.A:EffectofaspirinonCHDevents.
Testsforheterogeneity:
28.71,P0.367,I
28.2%.B:Effectofaspirinonriskofstrokeinpatientswithdiabetes.Testsforheterogeneity:
2
11.0, P  0.20, I
2  27.2%. BMD, British Medical Doctors; CI, conﬁdence interval; ETDRS, Early Treatment of Diabetic Retinopathy Study; HOT,
Hypertension Optimal Treatment; JPAD, Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes; PHS, Physicians’ Health Study;
POPADAD, Prevention of Progression of Arterial Disease and Diabetes; PPP, Primary Prevention Project; TPT, Thrombosis Prevention Trial; and
WHS, Women’s Health Study.
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